| |
|
|
|
Innovate Biopharmaceuticals Inc.  
|
|
0.8801 0.064 (0.08%) |
11-15 16:00 |
|
Open: |
0.8 |
Pre close: |
0.8165 |
Target:
|
1.15 
|
|
High: |
0.8999 |
Low: |
0.8 |
Resistance:
|
0.98
1.13
|
|
Volume: |
406,885 |
Market Cap: |
32M |
Support:
|
0.75
0.62
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.82
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
0.86 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
0.99 |
Stochastic Oscillator |
%K(14,3):
|
43.20 |
|
MA(250): |
1.58 |
%D(3): |
25.05 |
|
Average Volume(K) |
3-Month: |
17251
|
52-Week |
High:
|
4.32 |
|
10-Days: |
26839 |
Low: |
0.73 |
|
RSI |
RSI(14):
|
48.13 |
Change(%): |
-68.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.491 |
Return on Equity (ttm) |
-328.6 |
Shares Out. (M) |
35.88 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-65.9 |
Shares Float (M) |
23.70 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
43.23 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.70 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1260 |
|
Book Value (p.s.) |
0.140 |
EBITDA (p.s.) |
-0.376 |
P/E |
-1.79 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.29 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.64 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-8.72 |
P/CF |
-1.90 |
|
|
|
|
|
|
